STC Biologics is a boutique CDMO based in Newton, Massachusetts, that offers custom solutions for biologics drug development in preclinical and toxicology phases. The company offers a proprietary, cost-effective accelerated program that emphasizes speed-to-clinic (STC) for monoclonal antibodies, starting from cell line development to cGMP manufacturing of drug substance — all within 12 months. To date, STC Biologics has helped file 18 investigational new drug (IND) applications and eight biologics license applications (BLAs).